Funder
Lahore University of Management Sciences
Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Peterson LF, Boyapati A, Ahn E-Y, Biggs JR, Okumura AJ, Lo M-C, et al. Acute myeloid leukemia with the 8q22; 21q22 translocation: secondary mutational events and alternative t (8; 21) transcripts. Blood. J Am Soc Hematol. 2007;110:799–805.
2. Grafone T, Palmisano M, Nicci C, Storti S. An overview on the role of FLT3-tyrosine kinase receptor in acute myeloid leukemia: biology and treatment. Oncology Rev. 2012;6:64–74.
3. Gilliland DG, Griffin JD. The roles of FLT3 in hematopoiesis and leukemia. Blood J Am Soc Hematol. 2002;100:1532–42.
4. Levis M. FLT3 mutations in acute myeloid leukemia: what is the best approach in 2013? Hematology. 2013;2013:220–6.
5. Larrosa-Garcia M, Baer MR. FLT3 inhibitors in acute myeloid leukemia: current status and future directions. Mol Cancer Therapeut. 2017;16:991–1001.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献